News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Is Now the Time to Buy AstraZeneca PLC (AZN)?



11/30/2012 8:51:50 AM

I'm always searching for shares that can help ordinary investors like you make money from the stock market. So right now I am trawling through the FTSE 100 and giving my verdict on every member of the blue-chip index. Simply put, I'm hoping to pinpoint the very best buying opportunities in today's uncertain market. Today I am looking at AstraZeneca (LSE: AZN ) (NYSE: AZN ) to determine whether you should consider buying the shares at 2,930 pence. Trading on a projected P/E of 7.6, AstraZeneca looks cheaper than its peers in the Pharmaceutical & Biotech sector, which are currently trading on an average P/E of 11.4. However, AstraZeneca's P/E ratio and negative growth rate gives a PEG ratio of less than 0. With a negative result, the PEG ratio cannot help with my analysis.

Read at News Release


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES